About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Parkinsonís Disease Shows Changes in Brainstem

by Julia Samuel on January 8, 2018 at 1:20 PM
Font : A-A+

Parkinsonís Disease Shows Changes in Brainstem

Patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Experts at Newcastle and Sussex universities, UK, also revealed that surviving brain cells in the brainstem have more copies of mitochondrial DNA and this has not been identified before.

Advertisement


Dr Joanna Elson, a mitochondrial geneticist at Newcastle University, said: "Our study is a major step forward in gaining an enhanced insight into the serious condition. Only by understanding the complexities of what happens in specific cell-types found in specific areas of the brain during this disease can targeted treatments for Parkinson's disease be produced."

Changes in cell DNA

Research shows that in Parkinson's disease a brainstem region called the pedunculopontine nucleus (PPN) develops changes in DNA found in mitochondria - the batteries of the cell - as they produce and store energy that cells can use.
Advertisement

This study looked at cholinergic neurons that are responsible for producing the brain chemical acetylcholine, which is released by cholinergic nerve cells to send signals from one neuron to another.

Death of these cells in the PPN is believed to be the cause of some of the symptoms of Parkinson's disease, such as problems with attention, walking, and posture.

Identifying changes in the mitochondrial DNA in PPN cholinergic neurons has the potential to allow the development of more effective treatments targeted to specific cell-types.

The PPN is an understudied part of the brain and researchers used post-mortem tissue from the Newcastle Brain Bank, based at Newcastle University, to isolate single neurons for in-depth analysis.

Dr Ilse Pienaar, a neuroscientist at Sussex University, said: "At present, treatments are aimed at the whole brain of patient's with Parkinson's disease. "Only by understanding the complexities of what happens in specific cell-types found in specific areas of the brain during this disease can targeted treatments be produced. "We believe that not only would cell-specific targeted treatments be more effective, but they would also be associated with fewer side-effects."

The PPN was of interest because, in previous studies, patients with Parkinson's disease displayed lower levels of mitochondrial DNA (mtDNA) in remaining dopaminergic neurons.

This study showed that mtDNA levels are higher in the surviving cholinergic neurons of the brainstem, but with both cell-types that undergo profound degeneration during Parkinson's disease.

The finding identifies how vulnerable cell groups react and respond differently to the accumulation of mitochondrial DNA damage seen in the disease, highlighting the need for cell-specific treatments.

Parkinson's disease

Parkinson's disease is a condition in which part of the brain becomes progressively damaged over many years. It is estimated that around one in 500 people in the UK is affected by the condition.

Dr Elson said: "This is the only study to date to characterize mitochondrial DNA errors in cholinergic neurons, a neuronal population that is highly vulnerable to cell death in Parkinson's disease patients.

"With this work, we are beginning to understand the role that changes in mitochondrial DNA play in the death of cholinergic neurons, which has been shown to be pivotal in the onset and progression of motor and non-motor Parkinson's disease symptoms."

The team is now aiming to continue with further research to investigate the findings and test the mechanisms by which targeted treatment could be delivered to patients.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Nutritional Management of Parkinsons disease 

Recommended Reading
Language Areas in The Brain
The mechanism of how human brain processes the language to express and comprehend the verbal, ......
Brainstem Evoked Response Audiometry (BERA)
Brainstem evoked response audiometry records brain activity through the evoked potentials generated ...
Apomorphine: 150-Year-Old Drug Benefits Parkinson's Disease Patients
Apomorphine, a 150-year-old drug for Parkinson's disease is found to lower 'off' time for people at ...
Existance of Neurological Diseases Spotted by Brainwave Markers
COGNISION system can be used to detect brainwave markers that point to the existence of certain ......
Nutritional Management of Parkinsons disease
Parkinson's disease is a brain disorder which leads to many other related effects. Nutrition plays a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use